| Year |
Citation |
Score |
| 2021 |
Shin B, Hrdlicka HC, Delany AM, Lee SK. Inhibition of miR-29 activity in the myeloid lineage increases response to calcitonin and trabecular bone volume in mice. Endocrinology. PMID 34192317 DOI: 10.1210/endocr/bqab135 |
0.551 |
|
| 2021 |
Garcia J, Smith SS, Karki S, Drissi H, Hrdlicka HH, Youngstrom DW, Delany AM. miR-433-3p Suppresses Bone Formation and mRNAs Critical for Osteoblast Function in Mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 34004029 DOI: 10.1002/jbmr.4339 |
0.548 |
|
| 2020 |
Garcia J, Delany AM. microRNAs Regulating TGFβ and BMP Signaling in the Osteoblast Lineage. Bone. 115791. PMID 33285257 DOI: 10.1016/j.bone.2020.115791 |
0.376 |
|
| 2020 |
Hrdlicka HC, Pereira RC, Shin B, Yee SP, Deymier AC, Lee SK, Delany AM. Inhibition of miR-29-3p isoforms via tough decoy suppresses osteoblast function in homeostasis but promotes intermittent parathyroid hormone-induced bone anabolism. Bone. 115779. PMID 33253931 DOI: 10.1016/j.bone.2020.115779 |
0.568 |
|
| 2019 |
Shin B, Kupferman J, Schmidt E, Polleux F, Delany AM, Lee SK. Rac1 inhibition via Srgap2 restrains inflammatory osteoclastogenesis and limits the clastokine, SLIT3. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31880824 DOI: 10.1002/Jbmr.3945 |
0.407 |
|
| 2019 |
Hrdlicka HC, Lee SK, Delany AM. MicroRNAs are Critical Regulators of Osteoclast Differentiation. Current Molecular Biology Reports. 5: 65-74. PMID 30800633 DOI: 10.1007/s40610-019-0116-3 |
0.327 |
|
| 2019 |
Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E. Osteopenia and decreased bone formation in osteonectin-deficient mice The Journal of Clinical Investigation. 105: 1325. PMID 10792008 DOI: 10.1172/jci7039c1 |
0.338 |
|
| 2016 |
Smith SS, Dole NS, Franceschetti T, Hrdlicka HC, Delany AM. microRNA-433 Dampens Glucocorticoid Receptor Signaling, Impacting Circadian Rhythm and Osteoblastic Gene Expression. The Journal of Biological Chemistry. PMID 27551048 DOI: 10.1074/jbc.M116.737890 |
0.497 |
|
| 2016 |
Dole NS, Delany AM. MicroRNA variants as genetic determinants of bone mass. Bone. 84: 57-68. PMID 26723575 DOI: 10.1016/j.bone.2015.12.016 |
0.512 |
|
| 2015 |
Le LT, Swingler TE, Crowe N, Vincent TL, Barter MJ, Donell ST, Delany AM, Dalmay T, Young DA, Clark IM. The microRNA-29 family in cartilage homeostasis and osteoarthritis. Journal of Molecular Medicine (Berlin, Germany). PMID 26687115 DOI: 10.1007/s00109-015-1374-z |
0.476 |
|
| 2015 |
Pereira RC, Delany AM, Khouzam NM, Bowen RE, Freymiller EG, Salusky IB, Wesseling-Perry K. Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivo. Kidney International. 87: 593-601. PMID 25354236 DOI: 10.1038/ki.2014.347 |
0.425 |
|
| 2015 |
Dole NS, Kapinas K, Kessler CB, Yee SP, Adams DJ, Pereira RC, Delany AM. A single nucleotide polymorphism in osteonectin 3' untranslated region regulates bone volume and is targeted by miR-433. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 30: 723-32. PMID 25262637 DOI: 10.1002/Jbmr.2378 |
0.695 |
|
| 2015 |
Pereira RC, Delany AM, Khouzam NM, Bowen RE, Freymiller EG, Salusky IB, Wesseling-Perry K. Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivo Kidney International. 87: 593-601. DOI: 10.1038/ki.2014.347 |
0.425 |
|
| 2015 |
James EN, Delany AM, Nair LS. Corrigendum to “Post-transcriptional regulation in osteoblasts using localized delivery of miR-29a inhibitor from nanofibers to enhance extracellular matrix deposition” [Acta Biomater 10 (2014) 3571–3580] Acta Biomaterialia. 21: 251. DOI: 10.1016/J.ACTBIO.2015.04.028 |
0.441 |
|
| 2014 |
Franceschetti T, Dole NS, Kessler CB, Lee SK, Delany AM. Pathway analysis of microRNA expression profile during murine osteoclastogenesis. Plos One. 9: e107262. PMID 25222202 DOI: 10.1371/journal.pone.0107262 |
0.548 |
|
| 2014 |
James EN, Delany AM, Nair LS. Post-transcriptional regulation in osteoblasts using localized delivery of miR-29a inhibitor from nanofibers to enhance extracellular matrix deposition. Acta Biomaterialia. 10: 3571-80. PMID 24816265 DOI: 10.1016/j.actbio.2014.04.026 |
0.436 |
|
| 2013 |
Franceschetti T, Kessler CB, Lee SK, Delany AM. miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration. The Journal of Biological Chemistry. 288: 33347-60. PMID 24085298 DOI: 10.1074/jbc.M113.484568 |
0.53 |
|
| 2013 |
Smith SS, Kessler CB, Shenoy V, Rosen CJ, Delany AM. IGF-I 3' untranslated region: strain-specific polymorphisms and motifs regulating IGF-I in osteoblasts. Endocrinology. 154: 253-62. PMID 23183171 DOI: 10.1210/en.2012-1476 |
0.333 |
|
| 2012 |
Kapinas K, Lowther KM, Kessler CB, Tilbury K, Lieberman JR, Tirnauer JS, Campagnola P, Delany AM. Bone matrix osteonectin limits prostate cancer cell growth and survival. Matrix Biology : Journal of the International Society For Matrix Biology. 31: 299-307. PMID 22525512 DOI: 10.1016/J.Matbio.2012.03.002 |
0.65 |
|
| 2011 |
Kapinas K, Delany AM. MicroRNA biogenesis and regulation of bone remodeling. Arthritis Research & Therapy. 13: 220. PMID 21635717 DOI: 10.1186/Ar3325 |
0.679 |
|
| 2010 |
Kawai M, Delany AM, Green CB, Adamo ML, Rosen CJ. Nocturnin suppresses igf1 expression in bone by targeting the 3' untranslated region of igf1 mRNA. Endocrinology. 151: 4861-70. PMID 20685873 DOI: 10.1210/En.2010-0407 |
0.301 |
|
| 2010 |
Kapinas K, Kessler C, Ricks T, Gronowicz G, Delany AM. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. The Journal of Biological Chemistry. 285: 25221-31. PMID 20551325 DOI: 10.1074/Jbc.M110.116137 |
0.692 |
|
| 2009 |
Delany AM, Hankenson KD. Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. Journal of Cell Communication and Signaling. 3: 227-38. PMID 19862642 DOI: 10.1007/S12079-009-0076-0 |
0.446 |
|
| 2009 |
Kapinas K, Kessler CB, Delany AM. miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. Journal of Cellular Biochemistry. 108: 216-24. PMID 19565563 DOI: 10.1002/Jcb.22243 |
0.712 |
|
| 2008 |
Machado do Reis L, Kessler CB, Adams DJ, Lorenzo J, Jorgetti V, Delany AM. Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice. Bone. 43: 264-73. PMID 18499553 DOI: 10.1016/j.bone.2008.03.024 |
0.411 |
|
| 2008 |
Delany AM, McMahon DJ, Powell JS, Greenberg DA, Kurland ES. Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis Osteoporosis International. 19: 969-978. PMID 18084690 DOI: 10.1007/s00198-007-0523-9 |
0.377 |
|
| 2008 |
Delany A, Lowther K, Kapinas K, Kessler C, Nadiarnykh O, Campagnola P. P4. Poorly structured bone matrix, reminiscent of an “osteoblastic” lesion, promotes an aggressive gene expression profile in prostate carcinoma cells in vitro Cancer Treatment Reviews. 34: 13. DOI: 10.1016/J.Ctrv.2008.03.045 |
0.43 |
|
| 2007 |
Kessler CB, Delany AM. Increased Notch 1 expression and attenuated stimulatory G protein coupling to adenylyl cyclase in osteonectin-null osteoblasts. Endocrinology. 148: 1666-74. PMID 17218421 DOI: 10.1210/en.2006-0443 |
0.354 |
|
| 2003 |
Sciaudone M, Gazzerro E, Priest L, Delany AM, Canalis E. Notch 1 impairs osteoblastic cell differentiation. Endocrinology. 144: 5631-9. PMID 12960086 DOI: 10.1210/en.2003-0463 |
0.339 |
|
| 2003 |
Boskey AL, Moore DJ, Amling M, Canalis E, Delany AM. Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 18: 1005-11. PMID 12817752 DOI: 10.1359/Jbmr.2003.18.6.1005 |
0.388 |
|
| 2003 |
Delany AM, Kalajzic I, Bradshaw AD, Sage EH, Canalis E. Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology. 144: 2588-96. PMID 12746322 DOI: 10.1210/En.2002-221044 |
0.395 |
|
| 2002 |
Canalis E, Pereira RC, Delany AM. Effects of glucocorticoids on the skeleton. Journal of Pediatric Endocrinology & Metabolism : Jpem. 15: 1341-5. PMID 12510988 |
0.3 |
|
| 2002 |
Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Annals of the New York Academy of Sciences. 966: 73-81. PMID 12114261 |
0.409 |
|
| 2002 |
Pereira RC, Delany AM, Canalis E. Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone. 30: 685-91. PMID 11996905 DOI: 10.1016/S8756-3282(02)00687-7 |
0.368 |
|
| 2002 |
Pereira RM, Delany AM, Durant D, Canalis E. Cortisol regulates the expression of Notch in osteoblasts. Journal of Cellular Biochemistry. 85: 252-8. PMID 11948681 DOI: 10.1002/jcb.10125 |
0.334 |
|
| 2002 |
Delany AM, Pereira RM, Pereira RC, Canalis E. The cellular and molecular basis of glucocorticoid actions in bone. Frontiers of Hormone Research. 30: 2-12. PMID 11892267 DOI: 10.1159/000061068 |
0.338 |
|
| 1998 |
Delany AM, Canalis E. Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts. American Journal of Physiology. Cell Physiology. 274: C734-C740. PMID 29591129 DOI: 10.1152/ajpcell.1998.274.3.C734 |
0.342 |
|
| 1996 |
Gabbitas B, Pash JM, Delany AM, Canalis E. Cortisol inhibits the synthesis of insulin-like growth factor-binding protein-5 in bone cell cultures by transcriptional mechanisms. The Journal of Biological Chemistry. 271: 9033-8. PMID 8621551 DOI: 10.1074/jbc.271.15.9033 |
0.318 |
|
| 1996 |
Varghese S, Delany AM, Liang L, Gabbitas B, Jeffrey JJ, Canalis E. Transcriptional and posttranscriptional regulation of interstitial collagenase by platelet-derived growth factor BB in bone cell cultures. Endocrinology. 137: 431-7. PMID 8593786 DOI: 10.1210/endo.137.2.8593786 |
0.354 |
|
| 1995 |
Delany AM, Dong Y, Canalis E. Mechanisms of glucocorticoid action in bone cells. Journal of Cellular Biochemistry. 56: 295-302. PMID 7876321 DOI: 10.1002/jcb.240560304 |
0.415 |
|
| 1995 |
Delany AM, Jeffrey JJ, Rydziel S, Canalis E. Cortisol increases interstitial collagenase expression in osteoblasts by post-transcriptional mechanisms. The Journal of Biological Chemistry. 270: 26607-12. PMID 7592884 DOI: 10.1074/jbc.270.44.26607 |
0.339 |
|
| 1994 |
Delany AM, Pash JM, Canalis E. Cellular and clinical perspectives on skeletal insulin-like growth factor I. Journal of Cellular Biochemistry. 55: 328-33. PMID 7962164 DOI: 10.1002/jcb.240550309 |
0.352 |
|
| Show low-probability matches. |